Localization of an ovarian cancer tumor suppressor gene to a 0.5-cM region between D22S284 and CYP2D, on chromosome 22q

The detection of loss of heterozygosity, indicative of the presence of a tumor suppressor gene, has been reported to occur frequently on chromosome 22q in human ovarian cancer. In this study, 110 sporadic ovarian tumors were analyzed using 8 polymorphic loci to define a minimum region of loss. Fifty...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer research (Chicago, Ill.) Ill.), 1996-02, Vol.56 (4), p.719-721
Hauptverfasser: BRYAN, E. J, WATSON, R. H, DAVIS, M, HITCHCOCK, A, FOULKES, W. D, CAMPBELL, I. G
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 721
container_issue 4
container_start_page 719
container_title Cancer research (Chicago, Ill.)
container_volume 56
creator BRYAN, E. J
WATSON, R. H
DAVIS, M
HITCHCOCK, A
FOULKES, W. D
CAMPBELL, I. G
description The detection of loss of heterozygosity, indicative of the presence of a tumor suppressor gene, has been reported to occur frequently on chromosome 22q in human ovarian cancer. In this study, 110 sporadic ovarian tumors were analyzed using 8 polymorphic loci to define a minimum region of loss. Fifty-eight (53%) tumors showed loss of heterozygosity, and of these 6 exhibited partial loss, enabling the identification of two candidate tumor suppressor gene loci. One region, of less than 0.5 cM, is flanked by D22S284 and CYP2D, and a second region lies distal to D22S276. Analysis of loss of heterozygosity with respect to grade and stage suggests that chromosome 22q loss of heterozygosity is of more relevance in tumor progression rather than initiation.
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_78034286</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78034286</sourcerecordid><originalsourceid>FETCH-LOGICAL-h267t-aca4c7b24157153754430ec75d74f8e11e111db902d188762af4f5ecbe9a231f3</originalsourceid><addsrcrecordid>eNo9UE1LxDAQDaKs6-pPEHIQT1aSNGnSo6yfsKKgHjyVNJ3sVtqmm7Qu-uuNWIRh3gzvzYN5e2hORaoSybnYR3NCiEoEl-wQHYXwEVdBiZihmcpSSgibo93KGd3U33qoXYedxTr2T-3riEZ3BjwextZ5HMa-9xBCHNfQAR4c1phcisQ8Yg_r3-sShh1Ah68Ze2GKR6sKL9-f2fUFjqzZeNe64FrAjG2P0YHVTYCTCRfo7fbmdXmfrJ7uHpZXq2TDMjkk2mhuZMk4FTI-JgXnKQEjRSW5VUBpLFqVOWEVVUpmTFtuBZgScs1SatMFOv_z7b3bjhCGoq2DgabRHbgxFFKRlLMYxwKdTsKxbKEqel-32n8VU1KRP5t4HWJi1sdw6vAvY3nOpczSH4L5cCc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78034286</pqid></control><display><type>article</type><title>Localization of an ovarian cancer tumor suppressor gene to a 0.5-cM region between D22S284 and CYP2D, on chromosome 22q</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>American Association for Cancer Research</source><creator>BRYAN, E. J ; WATSON, R. H ; DAVIS, M ; HITCHCOCK, A ; FOULKES, W. D ; CAMPBELL, I. G</creator><creatorcontrib>BRYAN, E. J ; WATSON, R. H ; DAVIS, M ; HITCHCOCK, A ; FOULKES, W. D ; CAMPBELL, I. G</creatorcontrib><description>The detection of loss of heterozygosity, indicative of the presence of a tumor suppressor gene, has been reported to occur frequently on chromosome 22q in human ovarian cancer. In this study, 110 sporadic ovarian tumors were analyzed using 8 polymorphic loci to define a minimum region of loss. Fifty-eight (53%) tumors showed loss of heterozygosity, and of these 6 exhibited partial loss, enabling the identification of two candidate tumor suppressor gene loci. One region, of less than 0.5 cM, is flanked by D22S284 and CYP2D, and a second region lies distal to D22S276. Analysis of loss of heterozygosity with respect to grade and stage suggests that chromosome 22q loss of heterozygosity is of more relevance in tumor progression rather than initiation.</description><identifier>ISSN: 0008-5472</identifier><identifier>EISSN: 1538-7445</identifier><identifier>PMID: 8631002</identifier><identifier>CODEN: CNREA8</identifier><language>eng</language><publisher>Philadelphia, PA: American Association for Cancer Research</publisher><subject>Biological and medical sciences ; Chromosome Deletion ; Chromosome Mapping ; Chromosomes, Human, Pair 22 ; Cytochrome P-450 Enzyme System - genetics ; Endometrial Neoplasms - genetics ; Endometrial Neoplasms - pathology ; Female ; Female genital diseases ; Genes, Tumor Suppressor ; Genetic Markers ; Gynecology. Andrology. Obstetrics ; Humans ; Medical sciences ; Neoplasm Staging ; Ovarian Neoplasms - classification ; Ovarian Neoplasms - genetics ; Ovarian Neoplasms - pathology ; Polymerase Chain Reaction ; Polymorphism, Genetic ; Tumors</subject><ispartof>Cancer research (Chicago, Ill.), 1996-02, Vol.56 (4), p.719-721</ispartof><rights>1996 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2994776$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8631002$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>BRYAN, E. J</creatorcontrib><creatorcontrib>WATSON, R. H</creatorcontrib><creatorcontrib>DAVIS, M</creatorcontrib><creatorcontrib>HITCHCOCK, A</creatorcontrib><creatorcontrib>FOULKES, W. D</creatorcontrib><creatorcontrib>CAMPBELL, I. G</creatorcontrib><title>Localization of an ovarian cancer tumor suppressor gene to a 0.5-cM region between D22S284 and CYP2D, on chromosome 22q</title><title>Cancer research (Chicago, Ill.)</title><addtitle>Cancer Res</addtitle><description>The detection of loss of heterozygosity, indicative of the presence of a tumor suppressor gene, has been reported to occur frequently on chromosome 22q in human ovarian cancer. In this study, 110 sporadic ovarian tumors were analyzed using 8 polymorphic loci to define a minimum region of loss. Fifty-eight (53%) tumors showed loss of heterozygosity, and of these 6 exhibited partial loss, enabling the identification of two candidate tumor suppressor gene loci. One region, of less than 0.5 cM, is flanked by D22S284 and CYP2D, and a second region lies distal to D22S276. Analysis of loss of heterozygosity with respect to grade and stage suggests that chromosome 22q loss of heterozygosity is of more relevance in tumor progression rather than initiation.</description><subject>Biological and medical sciences</subject><subject>Chromosome Deletion</subject><subject>Chromosome Mapping</subject><subject>Chromosomes, Human, Pair 22</subject><subject>Cytochrome P-450 Enzyme System - genetics</subject><subject>Endometrial Neoplasms - genetics</subject><subject>Endometrial Neoplasms - pathology</subject><subject>Female</subject><subject>Female genital diseases</subject><subject>Genes, Tumor Suppressor</subject><subject>Genetic Markers</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Neoplasm Staging</subject><subject>Ovarian Neoplasms - classification</subject><subject>Ovarian Neoplasms - genetics</subject><subject>Ovarian Neoplasms - pathology</subject><subject>Polymerase Chain Reaction</subject><subject>Polymorphism, Genetic</subject><subject>Tumors</subject><issn>0008-5472</issn><issn>1538-7445</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9UE1LxDAQDaKs6-pPEHIQT1aSNGnSo6yfsKKgHjyVNJ3sVtqmm7Qu-uuNWIRh3gzvzYN5e2hORaoSybnYR3NCiEoEl-wQHYXwEVdBiZihmcpSSgibo93KGd3U33qoXYedxTr2T-3riEZ3BjwextZ5HMa-9xBCHNfQAR4c1phcisQ8Yg_r3-sShh1Ah68Ze2GKR6sKL9-f2fUFjqzZeNe64FrAjG2P0YHVTYCTCRfo7fbmdXmfrJ7uHpZXq2TDMjkk2mhuZMk4FTI-JgXnKQEjRSW5VUBpLFqVOWEVVUpmTFtuBZgScs1SatMFOv_z7b3bjhCGoq2DgabRHbgxFFKRlLMYxwKdTsKxbKEqel-32n8VU1KRP5t4HWJi1sdw6vAvY3nOpczSH4L5cCc</recordid><startdate>19960215</startdate><enddate>19960215</enddate><creator>BRYAN, E. J</creator><creator>WATSON, R. H</creator><creator>DAVIS, M</creator><creator>HITCHCOCK, A</creator><creator>FOULKES, W. D</creator><creator>CAMPBELL, I. G</creator><general>American Association for Cancer Research</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>19960215</creationdate><title>Localization of an ovarian cancer tumor suppressor gene to a 0.5-cM region between D22S284 and CYP2D, on chromosome 22q</title><author>BRYAN, E. J ; WATSON, R. H ; DAVIS, M ; HITCHCOCK, A ; FOULKES, W. D ; CAMPBELL, I. G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-h267t-aca4c7b24157153754430ec75d74f8e11e111db902d188762af4f5ecbe9a231f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Biological and medical sciences</topic><topic>Chromosome Deletion</topic><topic>Chromosome Mapping</topic><topic>Chromosomes, Human, Pair 22</topic><topic>Cytochrome P-450 Enzyme System - genetics</topic><topic>Endometrial Neoplasms - genetics</topic><topic>Endometrial Neoplasms - pathology</topic><topic>Female</topic><topic>Female genital diseases</topic><topic>Genes, Tumor Suppressor</topic><topic>Genetic Markers</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Neoplasm Staging</topic><topic>Ovarian Neoplasms - classification</topic><topic>Ovarian Neoplasms - genetics</topic><topic>Ovarian Neoplasms - pathology</topic><topic>Polymerase Chain Reaction</topic><topic>Polymorphism, Genetic</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>BRYAN, E. J</creatorcontrib><creatorcontrib>WATSON, R. H</creatorcontrib><creatorcontrib>DAVIS, M</creatorcontrib><creatorcontrib>HITCHCOCK, A</creatorcontrib><creatorcontrib>FOULKES, W. D</creatorcontrib><creatorcontrib>CAMPBELL, I. G</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer research (Chicago, Ill.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>BRYAN, E. J</au><au>WATSON, R. H</au><au>DAVIS, M</au><au>HITCHCOCK, A</au><au>FOULKES, W. D</au><au>CAMPBELL, I. G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Localization of an ovarian cancer tumor suppressor gene to a 0.5-cM region between D22S284 and CYP2D, on chromosome 22q</atitle><jtitle>Cancer research (Chicago, Ill.)</jtitle><addtitle>Cancer Res</addtitle><date>1996-02-15</date><risdate>1996</risdate><volume>56</volume><issue>4</issue><spage>719</spage><epage>721</epage><pages>719-721</pages><issn>0008-5472</issn><eissn>1538-7445</eissn><coden>CNREA8</coden><abstract>The detection of loss of heterozygosity, indicative of the presence of a tumor suppressor gene, has been reported to occur frequently on chromosome 22q in human ovarian cancer. In this study, 110 sporadic ovarian tumors were analyzed using 8 polymorphic loci to define a minimum region of loss. Fifty-eight (53%) tumors showed loss of heterozygosity, and of these 6 exhibited partial loss, enabling the identification of two candidate tumor suppressor gene loci. One region, of less than 0.5 cM, is flanked by D22S284 and CYP2D, and a second region lies distal to D22S276. Analysis of loss of heterozygosity with respect to grade and stage suggests that chromosome 22q loss of heterozygosity is of more relevance in tumor progression rather than initiation.</abstract><cop>Philadelphia, PA</cop><pub>American Association for Cancer Research</pub><pmid>8631002</pmid><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0008-5472
ispartof Cancer research (Chicago, Ill.), 1996-02, Vol.56 (4), p.719-721
issn 0008-5472
1538-7445
language eng
recordid cdi_proquest_miscellaneous_78034286
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; American Association for Cancer Research
subjects Biological and medical sciences
Chromosome Deletion
Chromosome Mapping
Chromosomes, Human, Pair 22
Cytochrome P-450 Enzyme System - genetics
Endometrial Neoplasms - genetics
Endometrial Neoplasms - pathology
Female
Female genital diseases
Genes, Tumor Suppressor
Genetic Markers
Gynecology. Andrology. Obstetrics
Humans
Medical sciences
Neoplasm Staging
Ovarian Neoplasms - classification
Ovarian Neoplasms - genetics
Ovarian Neoplasms - pathology
Polymerase Chain Reaction
Polymorphism, Genetic
Tumors
title Localization of an ovarian cancer tumor suppressor gene to a 0.5-cM region between D22S284 and CYP2D, on chromosome 22q
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T09%3A43%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Localization%20of%20an%20ovarian%20cancer%20tumor%20suppressor%20gene%20to%20a%200.5-cM%20region%20between%20D22S284%20and%20CYP2D,%20on%20chromosome%2022q&rft.jtitle=Cancer%20research%20(Chicago,%20Ill.)&rft.au=BRYAN,%20E.%20J&rft.date=1996-02-15&rft.volume=56&rft.issue=4&rft.spage=719&rft.epage=721&rft.pages=719-721&rft.issn=0008-5472&rft.eissn=1538-7445&rft.coden=CNREA8&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E78034286%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=78034286&rft_id=info:pmid/8631002&rfr_iscdi=true